Placement of the MammoSite ® breast brachytherapy catheter is most commonly performed either intraoperatively or under ultrasound-guided technique. Below, we present a case report of an alternate approach utilizing CT-scan guidance. This is the first reported case of a balloon brachytherapy catheter placement with this technique.
Introduction
The standard breast conservation therapy approach in the treatment of breast cancer consists of complete excision of the primary tumor followed by a course of radiation to the entire breast. However, only approximately 60% to 86% of patients managed with breast conserving surgery ultimately receive postlumpectomy radiation (1, 2) . Although this may be due, in part, to a clinical decision made by the patient and the treating physician to forego radiotherapy, the patient's reluctance to undergo a 6 to 7 week course of daily treatment is also likely to be a significant obstacle in the limitation of radiation therapy's role in their treatment (3) (4) (5) . Thus, time compressed radiation regimens may significantly increase the rate of breast preservation, avoiding total mastectomy in patients who do not have the ability or the desire to receive six to seven weeks of daily radiation treatment.
Alternate approaches to standard fractionated courses of radiation include the "Canadian fractionation," offering 42.5 Gy whole-breast irradiation in 16 daily fractions as described by Whelan et al. (6) . as well as the various techniques of accelerated partial breast irradiation (APBI). APBI techniques prescribe radiation only to the high-risk breast tissue around the lumpectomy cavity and, as such, allow high doses of radiation to be delivered over approximately 1 week with acceptable toxicity (7). Currently, the most common methods of delivering APBI include conformal external beam radiotherapy, and brachytherapy via MammoSite ® radiation therapy system (RTS), newer cavity expandable implants or multicatheter interstitial implants. Collectively, these three modalities are currently being compared with standard whole-breast radiation in the phase III NS-ABP B-39/RTOG 0413 APBI trial (8).
The MammoSite ® RTS is a simple approach to APBI, consisting of a 15 cm long double-lumen balloon catheter that is designed specifically for breast brachytherapy. The device is typically placed either intraoperatively following the patient's breast conserving surgery, or via a closed technique with ultrasound guidance. Placing the device intraoperatively allows the patient to undergo only one procedure, the lumpectomy, sentinel node biopsy, and placement of the MammoSite ® . This technique, however, will have a percentage of patients with the MammoSite ® in place for a few days, then removed, if the Technology in Cancer Research & Treatment, Volume 8, Number 3, June 2009 pathology reveals certain criteria, such as positive margins or extensive nodal involvement.
Placement of the MammoSite ® postoperatively is typically performed within 2 weeks of surgery, but up to 10 weeks has been reported (9). Although the patients undergo a second procedure, this technique allows the advantage of confirming the final pathologic findings prior to placing the brachytherapy catheter. Thus only APBI candidates will undergo catheter placement. This is the preferred approach at our institution due to both logistical factors and the availability of the final pathologic report.
Case Report
Recently, a 56 year-old patient had been evaluated in our department with a new diagnosis of left-sided breast cancer. On mammography, she was noted to have a 1 cm mass, and subsequent biopsy confirmed the diagnosis of moderately differentiated infiltrating ductal carcinoma. After consultation with both the surgeon and the radiation oncologist, the patient opted for treatment with breast conserving therapy. The patient subsequently underwent lumpectomy, and pathologic review confirmed the presence of a 1 cm focus of moderately differentiated infiltrating ductal carcinoma of the left breast; surgical margins were free of tumor, and a sentinel lymph node biopsy was also negative for metastatic disease. The patient subsequently presented for further management. The patient wished to undergo MammoSite ® APBI.
However, at the time of presentation, the ultrasound probe was unavailable for use. This was discussed with the patient; she was offered a standard course of breast irradiation but remained reluctant. Therefore the decision was made to place the device under CT guidance.
The patient was brought to the CT simulator in the radiation oncology department, where the lumpectomy scar was demarcated with a radio-opaque wire. The patient then underwent a preliminary CT scan, whereby the lumpectomy cavity was located, adequate cavity-to-skin distance was confirmed, and the ideal approach for placement of the catheter was determined. The patient was prepped and draped with a sterile technique and lidocaine was infiltrated into the skin and breast tissue to provide local anesthesia. An 18-gauge needle was then inserted via the previously determined approach, and advanced until retraction of seroma fluid occurred. A repeat CT scan was performed at that time to confirm the presence of the needle tip at the lumpectomy cavity site (Figure 1) . A small nick was created in the skin as is customary with the ultrasound-guided technique, and the trochar was introduced in the same orientation and direction as was used with the needle. The MammoSite ® catheter was subsequently placed. A CT was taken to verify the position of the uninflated balloon catheter. The balloon was then filled with radio-opaque contrast material. A final CT scan was performed at that time; this was used both to confirm adequate placement of the balloon and for brachytherapy treatment planning ( Figure 2) . The wound was subsequently cleaned and dressed. The entire procedure required 32 minutes to complete. The planning process took another 35 minutes. The patient began treatment 67 minutes from when she first entered the department.
Subsequently, the patient underwent an uncomplicated course of APBI, receiving 34 Gy in ten twice-daily fractions, delivered to the breast tissue 1 cm beyond the surface of the brachytherapy balloon. The patient received twice daily CT scans to confirm that there was no change in the balloon geometry. The patient was given a course of oral antibiotics as is our standard protocol; she developed no evidence of cellulitis. After completion of therapy, the catheter was removed without incident. The patient has remained in good health, and without treatment-related toxicity.
Discussion
When a MammoSite ® is being placed using the closed technique under ultrasound, a patient would undergo MammoSite ® placement, treatment planning, and the first HDR fraction on the same day, with the time from when the patient enters the office for placement and they receive their first treatment typically well over 2 hours. In our experience, a patient requires a mean of 38 minutes (range 25-53) for successful ultrasound placement. There is some transit time from the surgeon's office to the radiation department. Then, the patient received a CT scan and manipulation as needed as described above, mean 25 minutes (range 11-75). Finally, a mean 44 minutes (range 32-65) are needed for planning. Our experience using ultrasound guided placement of MammoSite ® , showed a mean of 97 minutes for insertion, CT scanning and planning, not including any patient transit time, prior to treatment. Using the CT for placement of the MammoSite ® , the overall time from placement to treatment was 67 minutes.
Although the time between MammoSite ® insertion and treatment planning is not strictly defined by either the NSABP B-39 protocol (10) or American College of Breast Surgeons registry trial (9), some recommend waiting 24 hours after placement of the balloon applicator to CT planning to minimize air pocketing. Our practice is to CT the patient immediately after insertion, and to wait 24 hours and reimage the patient if air pockets or asymmetry exist. In our experience of 57 MammoSite ® placements, we waited and reimaged for treatment planning on 7 patients. We previously published our series on waiting between insertion and CT planning for asymmetrical center channel on 3 patients (11). The other 4 patients we repeated the planning CT due to air pocketing, which resolved in 24 hours for all 4 patients.
After placement of a MammoSite ® applicator by ultrasound, the patient must undergo a CT or x-ray for placement verification and for treatment planning. In our experience of 57 ultrasound guided MammoSite ® placements, 44 (77.2%) required manipulation of the fluid volume and placement after the initial CT, requiring another CT. Of those patients, 32 (56.1%) required more manipulation after the second CT. This means 56.1% of patients required 3+ CT's, 21.1% required 2, and 22.8% required 1 CT after placement, for planning. This patient required a total of 4 CT's for placement and planning.
As MammoSite ® brachytherapy imaging should be done to verify confirmation of acceptable cavity size and catheter placement, either with ultrasound or CT, CT is most commonly used for treatment planning. Since most modern radiation oncology centers have either their own CT simulators or have easy access to a CT, this insertion technique would not require the additional expense of purchasing a separate ultrasound tool for placement of the brachytherapy catheter. A disadvantage to this technique would be the CT scan time requirement; however, if a CT scanner is readily available to the radiation oncologist, this should not add any burden or decrease efficiency.
Another disadvantage of utilizing this technique would be the additional radiation exposure due to repeated CT scans that might be required during placement of the catheter. With conventional ultrasound placement, no radiation is administered in the placement of the MammoSite ® , until the patient receives a treatment planning CT or x-ray. This, however, does not strike the authors as major barrier, as the dose to the normal structures (i.e., the contralateral breast) due to these scans is far less than that delivered during the subsequent ABPI treatment. The average dose delivered to the contralateral breast from MammoSite ® brachytherapy was found to be 400 cGy (+200 cGy) (12). This is markedly lower than the dose delivered by a CT scan. A CT scan of the body delivers an estimated dose in mGy (13), in the range of 20 mGy or 2 cGy (14).
Using this technique, a patient would undergo 1-3 more CT scans than a typical ultrasound placed MammoSite ® . Over a course of a week of treatment, with a CT scan prior to each fraction, a patient would receive a minimum of 11 CT scans (only 22.8% of our series), which would total to a estimated minimum dose of 22 cGy from the diagnostic imaging. Our patient received 14 CT scans over the course of treatment, with an estimated total dose of 28 cGy from the diagnostic imaging, a 27% increase. When compared to the dose delivered to the contralateral breast from brachytherapy (400 cGy), the total dose delivered by the diagnostic imaging is <10%, with the increase due to additional CT scans is 1.5%. Our report appears to be the first description of CT-guided placement of the MammoSite ® catheter. Although it was performed due to an unplanned unavailability of the ultrasound probe, the procedure was found to be quite easy to perform and did not require more time to complete than the closed ultrasound-guided approach, if not less. CT guidance has been described for placement of interstitial catheter placement (15), but as more new hybrid applicators are developed (SAVI, Clear-path, etc.) which cannot be visualized by ultrasound, placement of APBI applicators under CT guidance will become more common.
Conclusion
The placement of the MammoSite ® brachytherapy catheter under CT-Scan guidance was found to be easy to perform, as the technique is largely identical to that used with the ultrasound-guided technique. The procedure saved physician and patient time (67 minutes, versus a mean of 97 minutes) and did not require the patient to undergo two different radiographic procedures, ultrasound, and CT. We feel that this technique warrants further study, and a case series will be collected prospectively in this regard.
